Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - Nature, 2021 - nature.com
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding. Translating these risk variants into mechanistic …

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - Nature, 2021 - edoc.mdc-berlin.de
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding. Translating these risk variants into mechanistic …

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - Nature, 2021 - econpapers.repec.org
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding1. Translating these risk variants into mechanistic …

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.

J Chiou, R Geusz, ML Okino, J Han, M Miller, R Melton… - Nature, 2021 - escholarship.org
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding1. Translating these risk variants into mechanistic …

[PDF][PDF] Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - Nature, 2021 - msanderlab.org
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding 1. Translating these risk variants into …

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - Nature, 2021 - europepmc.org
Genetic risk variants identified in genome-wide association studies (GWAS) of complex
disease are primarily non-coding 1, and translating risk variants into mechanistic insight …

[HTML][HTML] Interpreting type 1 diabetes risk with genetics and single cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - Nature, 2021 - ncbi.nlm.nih.gov
Genetic risk variants identified in genome-wide association studies (GWAS) of complex
disease are primarily non-coding 1, and translating risk variants into mechanistic insight …

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - Nature, 2021 - ideas.repec.org
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding1. Translating these risk variants into mechanistic …

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding 1. Translating these risk variants into …

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

J Chiou, RJ Geusz, ML Okino, JY Han, M Miller… - paper.sciencenet.cn
Genetic risk variants that have been identified in genome-wide association studies of
complex diseases are primarily non-coding1. Translating these risk variants into mechanistic …